Stock screenerAll disclosures →
EDGAR →
PGEN
Conviction 99HealthcareScan · Mon, Aug 10, 2026PGEN$6.99-3.32%
ResistanceSupportVol 14Insider sell5
Vol MA14 6.15M
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price6.99
Change-3.32%
Gap-0.69%
Rel volume1.95×
Avg volume5.29M
Avg $ vol32.69M
SMA 205.84
SMA 505.25
SMA 2004.37
Price vs 50+33.26%
Price vs 200+59.80%
MA stackbullish
50/200 cross—
Supertrendup · 5.95
RSI (14)71
MACD hist0.14
MACD crossbull · 7d
Stoch %K / %D85 / 90
ADX (14)33
+DI / −DI34 / 8
RSI divergence—
MACD divergence—
ATR %+5.48%
ADR %6.08%
52w high7.23
52w low1.74
From 52w high-3.32%
Above 52w low+301.72%
New 52w highNo
SqueezeOff
Bollinger width51.01%
%B0.89
Donchian pos87.03%
Donchian high7.32
Donchian low4.81
AVWAP (52w high)7.09
vs AVWAP high-1.46%
AVWAP (52w low)4.11
vs AVWAP low+70.13%
OBV trendUp
Chaikin MF (20)0.12
Today vs 20d1.95×
Avg vol (14d)6.15M
Avg vol (20d)5.29M
Avg $ vol (20d)32.69M
Market cap2.5B
RS 3m (vs SPY)+68.52%
RS 6m (vs SPY)+56.40%
RS line new highYes
Trend template8/8
Technical rank93.5
1 week+5.75%
1 month+31.39%
3 months+66.03%
6 months+62.94%
1 year+271.81%
YTD+63.32%
P/E-9.98
P/B57.43
P/S258.43
P/FCF-27.86
EPS-1.37
Div yield—
ROE-575.18%
ROA-147.18%
Debt/Eq3.15
Current4.58
EV/EBITDA-24.45
Gross margin—
Net margin—
Rev growth146.73%
EPS growth-98.55%
Price target14.50
Target upside107.44%
Analyst ratingBuy
Institutional41.76%
Ent. value2.62B
Revenue54.98M
Net income20.07M
Gross profit—
Free cash flow-89.83M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out—
Employees47
ListedThu, Aug 8, 2013
Free float174.65M
Float %49.0%
Short interest41.03M
Days to cover9.6d
Short volume42.7%
Squeeze score81 / 100
Next earnings—
EPS forecast—
Last EPS vs est$0.05 vs −$0.02
Last surprise+350.0% beat
Setup gradeA+
Conviction99 / 100
Pattern quality—
Tech rank93.5 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance5.92
Support4.70
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in PGEN
No recent disclosed trades by Congress in PGEN. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in PGEN · 1 buy · 9 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Shah Rutul R Chief Operating Officer · Common Stock · 2026-08-06 | Sell | 32.74K | $225K | 2026-08-06 | 2026-08-07 |
Thomasian Harry Jr. Chief Financial Officer · Common Stock · 2026-05-28 | Sell | 41.88K | $183K | 2026-05-28 | 2026-06-01 |
Shah Rutul R Chief Operating Officer · Common Stock · 2026-05-28 | Sell | 42.7K | $186K | 2026-05-28 | 2026-06-01 |
Sabzevari Helen President and CEO · Common Stock · 2026-05-28 | Sell | 119.25K | $520K | 2026-05-28 | 2026-06-01 |
Lehr Donald P. Chief Legal Officer · Common Stock · 2026-05-28 | Sell | 29.13K | $127K | 2026-05-28 | 2026-06-01 |
Tennant Phil Chief Commercial Officer · Common Stock · 2026-05-28 | Sell | 30.27K | $132K | 2026-05-28 | 2026-06-01 |
Lehr Donald P. Chief Legal Officer · Common Stock · 2026-05-23 | Exercise | 62.5K | — | 2026-05-23 | 2026-05-27 |
Lehr Donald P. Chief Legal Officer · Restricted Stock Units · 2026-05-23 | Exercise | 62.5K | $0 | 2026-05-23 | 2026-05-27 |
Tennant Phil Chief Commercial Officer · Restricted Stock Units · 2026-05-23 | Exercise | 62.5K | $0 | 2026-05-23 | 2026-05-27 |
Sabzevari Helen President and CEO · Restricted Stock Units · 2026-05-23 | Exercise | 250K | $0 | 2026-05-23 | 2026-05-27 |
SEC filings
EDGAR filings in PGEN · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.